Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Alarm threshold of interstitial glucose monitors: Consensus on advantages and disadvantages via a Delphi panel

  • Clémence Fradet*
  • , Bruno Guerci
  • , Hélène Hanaire
  • , Élise Bismuth
  • , Élisabeth Bonnemaison
  • , Sophie Borot
  • , Bogdan Catargi
  • , Anne Farret
  • , Didier Gouet
  • , Michael Joubert
  • , Alfred Penfornis
  • , Jean Pierre Riveline
  • , Sabine Rudoni
  • , Pauline Schaepelynck
  • , Agnès Sola-Gazagnes
  • , Jonathan Guillemot
  • *Autor correspondiente de este trabajo
  • Amaris
  • Hôpital d'adultes de Brabois
  • CNRS and Université Paul Sabatier
  • service d'endocrinologie et diabétologie pédiatriques
  • Centre Hospitalier Régional Universitaire de Tours
  • Hôpital Jean Minjoz
  • service d'endocrinologie-maladies métaboliques
  • CHU Montpellier
  • Université Paris Cité
  • Université de Caen
  • Université Paris-Saclay
  • Inserm
  • Hospital General
  • pôle ENDO
  • Cochin Hospital
  • Hospital de los Valles

Producción científica: Contribución a una revistaEstudio breverevisión exhaustiva

Resumen

There's a paucity of data on alarms for continuous glucose monitors (CGM) in the literature. The aim of this study was to reach a consensus on the advantages and disadvantages of glucose threshold alarms through a Delphi panel. This method is a decision-support tool to gather expert opinions on a specific topic. These alarms have demonstrated numerous benefits for diabetic patients, allowing them to have better control of their condition, and provide more reassurance to their family and/or caregivers. Moreover, the CGM alarms help patients to improve their daily life during work, school, and sport. However, they can also cause considerable inconvenience. An overwhelming number of alarms per day can embarrass, discourage or lead patients to inappropriate decision-making. In conclusion, the flexibility of being able to opt for these alarms is an important criterion for a tailored and personalised treatment regimen of the patients.

Idioma originalInglés
Páginas (desde-hasta)608-616
Número de páginas9
PublicaciónMedecine des Maladies Metaboliques
Volumen14
N.º7
DOI
EstadoPublicada - nov. 2020

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Alarm threshold of interstitial glucose monitors: Consensus on advantages and disadvantages via a Delphi panel'. En conjunto forman una huella única.

Citar esto